Regulation of glucose metabolism using anti-cgrp antibodies

摘要: The present disclosure provides methods for the prevention or treatment of metabolic disorders. In exemplary embodiments, administering an anti-CGRP antibody are provided, optionally in combination with a second agent, wherein peripheral and/or hepatic glucose utilization is increased, thereby preventing treating diseases and disorders associated insulin resistance. Compositions comprising also which suitable administration to increase prevent treat